We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CORI
1926
DELISTED
Corium International, Inc.
CORI
| $317K | ﹤0.01% |
+33,000
| New | +$352K |
|
|
DSKE
1927
DELISTED
Daseke, Inc. Common Stock
DSKE
| $316K | ﹤0.01% |
+22,100
| New | +$296K |
|
|
ACHN
1928
DELISTED
Achillion Pharmaceuticals
ACHN
| $314K | ﹤0.01% |
+108,913
| New | +$396K |
|
1929
RLI Corp
RLI
$5.68B
| $312K | ﹤0.01% |
10,284
-18,600
| -64% | -$546K |
|
|
MN
1930
DELISTED
MANNING & NAPIER, INC.
MN
| $312K | ﹤0.01% |
86,639
-10,000
| -10% | -$37.6K |
|
1931
Winmark
WINA
$1.19B
| $311K | ﹤0.01% |
2,400
-300
| -11% | -$39.7K |
|
|
CYS
1932
DELISTED
CYS Investments Inc.
CYS
| $311K | ﹤0.01% |
38,744
+2,966
| +8% | +$24.5K |
|
|
GPX
1933
DELISTED
GP Strategies Corp.
GPX
| $309K | ﹤0.01% |
13,300
+2,700
| +25% | +$70.5K |
|
1934
Materion
MTRN
$5.01B
| $308K | ﹤0.01% |
+6,347
| New | +$302K |
|
1935
Univest Financial
UVSP
$1.23B
| $308K | ﹤0.01% |
+10,984
| New | +$325K |
|
|
WBT
1936
DELISTED
Welbilt, Inc.
WBT
| $308K | ﹤0.01% |
+13,100
| New | +$289K |
|
1937
RE/MAX Holdings
RMAX
$200M
| $307K | ﹤0.01% |
+6,323
| New | +$361K |
|
1938
Steris
STE
$20.9B
| $306K | ﹤0.01% |
+3,500
| New | +$312K |
|
|
CPRX
1939
DELISTED
Catalyst Pharmaceutical
CPRX
| $305K | ﹤0.01% |
+78,092
| New | +$258K |
|
1940
Dime Commercial Bancshares
DCOM
$1.75B
| $304K | ﹤0.01% |
8,697
-3,100
| -26% | -$108K |
|
1941
First Community Bankshares
FCBC
$915M
| $304K | ﹤0.01% |
10,574
-300
| -3% | -$8.82K |
|
1942
Alamo Group
ALG
$2.01B
| $299K | ﹤0.01% |
2,647
-100
| -4% | -$11.2K |
|
1943
Estee Lauder
EL
$29B
| $299K | ﹤0.01% |
2,350
-244,500
| -99% | -$29.4M |
|
1944
Immersion
IMMR
$216M
| $299K | ﹤0.01% |
42,314
-51,200
| -55% | -$371K |
|
1945
RBC Bearings
RBC
$18.8B
| $299K | ﹤0.01% |
2,366
-200
| -8% | -$25.1K |
|
1946
Riverview Bancorp
RVSB
$107M
| $299K | ﹤0.01% |
34,500
+7,500
| +28% | +$66.5K |
|
1947
SiriusPoint
SPNT
$2.98B
| $299K | ﹤0.01% |
20,400
+8,100
| +66% | +$130K |
|
|
SHPG
1948
DELISTED
Shire pic
SHPG
| $298K | ﹤0.01% |
1,919
-314,582
| -99% | -$46.6M |
|
1949
Forward Air
FWRD
$482M
| $295K | ﹤0.01% |
5,142
-5,100
| -50% | -$292K |
|
1950
Park National Corp
PRK
$3.41B
| $294K | ﹤0.01% |
2,830
-200
| -7% | -$21.7K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.